LUISA P SANTOS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health ROSLYN, NY NPI 1265747604
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Adult Health NY Novo Nordisk AS All categories
General Payments — all program years on this page
$656.53
- Category: General Payments
- Program years: PY2021–2024
- Record count: 36
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $156.26 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $156.26 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $60.39 | 3 |
| Abbott Laboratories | $23.23 | 1 |
| PFIZER INC. | $22.56 | 1 |
| E.R. Squibb & Sons, L.L.C. | $18.05 | 1 |
| Acerta Pharma LLC | $17.30 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.73 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1087301049 | Novartis Pharmaceuticals Corporation | $14.73 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100564100 | Novo Nordisk Inc | $19.44 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100622714 | Novo Nordisk Inc | $19.75 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1100651203 | Novo Nordisk Inc | $21.20 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101396875 | E.R. Squibb & Sons, L.L.C. | $18.05 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104763554 | AstraZeneca Pharmaceuticals LP | $17.30 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1124938868 | Abbott Laboratories | $23.23 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1131105318 | PFIZER INC. | $22.56 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.